Tan, Yue
Pan, Jing http://orcid.org/0000-0002-6272-6849
Deng, Biping
Ling, Zhuojun
Song, Weiliang
Xu, Jinlong
Duan, Jiajia
Wang, Zelin
Yu, Xinjian
Chang, Alex H.
Feng, Xiaoming
Funding for this research was provided by:
the National Key R&D Program of China (2019YFA0110200)
the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2018PT32034)
the Tianjin Science Funds for Distinguished Young Scholars (17JCJQJC45800)
Article History
Received: 3 July 2020
Accepted: 10 December 2020
First Online: 8 January 2021
Compliance with ethical standards
:
: AHC is also a founding member of Shanghai YaKe Biotechnology Ltd. The remaining authors declare no conflict of interest.
: The study protocols were approved by the institutional review board at Beijing Boren hospital, and the patients provided written informed consent. This clinical investigation was conducted according to the principles of the Declaration of Helsinki.